<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190529043754N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-03-29</date_registration>
      <primary_sponsor>Shahroud University of Medical Sciences</primary_sponsor>
      <public_title>The effect of health promoting lifestyle educational program on infertile couple who candidate for Assisted reproductive technology.</public_title>
      <acronym></acronym>
      <scientific_title>Determining the effectiveness of a health-promoting lifestyle training program in infertile couples under Assisted Reproductive Technologies (ART).</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-04-09</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>150</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/58233</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: After primary selection, the samples will be divided into two groups by simple sampling method, using a random block of 4, with an allocation ratio of 1: 1. Then, by listing all the  Possible mods of  blocks of 4 and assign numbers to each of them, with  use  computer random numbers with 1:1 allocation ratios, Participants  will be divided into two groups of intervention and control.

Community Verified icon, Blinding description: The sequence is provided to the researcher by a statistical consultant using a website. Then sealed envelope will be used According to the sequence produced, the blocks are designed and placed in closed envelopes. As soon as the eligible patient enters, the envelopes are opened in order and According to the letter.هside  them, they will  assigned to one of the groups' treatment or control. Patient information will recorded by the research team.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Infertility.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention group will included 75 infertile couples (men and women) undergoing infertility treatments.The training program will be in three dimensions.                       1- physical activity: The intervention group will perform physical activity home-based exercise  and balanced walking with progressive muscle relaxation. in the end of activity they will do deep diaphragmatic breathing. exercise. Pattern of activity will be  3 times a week, for 45 minutes, In moderate intensity in 8 sessions before the onset of ovulation stimulation.              Diet: In the intervention group, nutrition will include adjusting calorie intake based on participants' body mass index classification along with receiving the standard 5 main food groups with Mediterranean diet in 8 sessions before the onset of ovulation stimulation. The food frequency questionnaire will be completed.                                                                                         Stress management: In the intervention group, stress management will be based on the Mindfulness program. Training and counseling sessions will be held in personally and virtually for 8 sessions of 60 minutes, once a week.The content of the sessions begins with an introduction and welcome, then will continue to introduce stress and the mechanism of the effect of stress on the body, familiarity with the reproductive system, causes of infertility and infertility treatment methods. Training in the next sessions will include progressive  muscle relaxation, ecstasy, diaphragmatic breathing, self-help, strengthening self-reconciliation, recognizing strengths and weaknesses, problem solving, forgiving oneself and others, compassion for oneself and others, sharing experiences. Training will be done 6 sessions before the onset of ovulation and 2 sessions in the waiting period until the pregnancy test is positive. Pr-test and post-test will  perform. Intervention 2: Control group:                                                                                                                                                 75 infertile  under treatment couples  in the control group will receive lactation education.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The data can be published after the completion of the dissertation

When:
One year after completing the dissertation

To whom:
Shahroud University of Medical Sciences; Hospital and university researchers

Conditions:
Data will be available after publication in journals

Where to obtain:
Padideh Malekpour
padideh_66@yahoo.com
Correspondence Address: Shahroud University of Medical Sciences, Hafte Tir Square, Shahroud, Iran
 Phone: 023-32395054

How to obtain:
The information will be available through the publication
of the article. But if more information is needed, the
request should be sent via email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Padideh Malekpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahroud University of Medical Sciences, Hafte Tir Square, Shahroud, Iran</address>
        <city>Shahroud</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۳۶۱۴۷-۷۳۹۴۳</zip>
        <telephone>4 +98 23 3234 2000</telephone>
        <email>padideh_66@yaoo.com</email>
        <affiliation>Shahroud University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr.Zahra Motaghi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahroud University of Medical Sciences and Health Service building, Hafte Tir Square,, Shahroud, Iran.</address>
        <city>Shahroud</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۳۶۱۴۷-۷۳۹۴۳</zip>
        <telephone>+98 23 3239 5054</telephone>
        <email>zhrmotaghi@yahoo.com</email>
        <affiliation>Shahroud University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Interested in participating in the study,
Assisted Reproductive  Technology candidate couples
Could read and write
First or second  infertility Treatment,</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Diagnosed for  mental or psychotic  disorders
Diagnosed for Chronic illnesses</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N97</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Female infertility</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention group will included 75 infertile couples (men and women) undergoing infertility treatments.The training program will be in three dimensions.                       1- physical activity: The intervention group will perform physical activity home-based exercise  and balanced walking with progressive muscle relaxation. in the end of activity they will do deep diaphragmatic breathing. exercise. Pattern of activity will be  3 times a week, for 45 minutes, In moderate intensity in 8 sessions before the onset of ovulation stimulation.              Diet: In the intervention group, nutrition will include adjusting calorie intake based on participants' body mass index classification along with receiving the standard 5 main food groups with Mediterranean diet in 8 sessions before the onset of ovulation stimulation. The food frequency questionnaire will be completed.                                                                                         Stress management: In the intervention group, stress management will be based on the Mindfulness program. Training and counseling sessions will be held in personally and virtually for 8 sessions of 60 minutes, once a week.The content of the sessions begins with an introduction and welcome, then will continue to introduce stress and the mechanism of the effect of stress on the body, familiarity with the reproductive system, causes of infertility and infertility treatment methods. Training in the next sessions will include progressive  muscle relaxation, ecstasy, diaphragmatic breathing, self-help, strengthening self-reconciliation, recognizing strengths and weaknesses, problem solving, forgiving oneself and others, compassion for oneself and others, sharing experiences. Training will be done 6 sessions before the onset of ovulation and 2 sessions in the waiting period until the pregnancy test is positive. Pr-test and post-test will  perform.</i_keyword>
      <i_keyword>Control group:                                                                                                                                                 75 infertile  under treatment couples  in the control group will receive lactation education.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Primary outcome:                                                                                                                              Chemical pregnancy by  Beta human chronic gonadotrophin (B-hCG) blood  test. Timepoint: 4 and 6 week after pregnancy. Method of measurement: Blood test to diagnose pregnancy by (Beta-hCG) test.</prim_outcome>
      <prim_outcome>Clinical pregnancy (diagnosis of fetal heart rate at 6 weeks with ultrasound). Timepoint: Weeks 4 and 6 of pregnancy. Method of measurement: Hearing the sound of the fetal heart during the 6th week of pregnancy by ultrasound.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Live Birth. Timepoint: Delivery after 24 week of pregnancy. Method of measurement: Neonate delivered  via natural or cesarean.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor for research, Shahroud University  of medical sciences.</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-04-20</approval_date>
        <contact_name>Ethics Committee of Shahroud University of Medical Sciences</contact_name>
        <contact_address>Sharoud medical science and health service university, Hafte tir square, Shahroud, Iran. Shahroud Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
